Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
mig [2022/08/14 03:21] – [Migraine] sflitmanmig [2022/08/14 03:21] (current) – [Migraine] sflitman
Line 4: Line 4:
  
 ^ Condition(s)  ^ Type of Drug  ^  Phase  ^  Add-On  ^  Placebo  ^  Duration  ^  Open-Label Extension  ^  ^ Condition(s)  ^ Type of Drug  ^  Phase  ^  Add-On  ^  Placebo  ^  Duration  ^  Open-Label Extension  ^
-| Adult episodic migraine preventive |  Oral gepant  |  III  |  Yes  |  50%  |   24 weeks  |+| Adult episodic migraine preventive |  Novel oral gepant  |  III  |  Yes  |  50%  |   24 weeks  |
 | Adult episodic migraine preventive + abortive  |  Atogepant + Ubrogepant  |  IV  |  No |  0%  |   52 weeks  | | Adult episodic migraine preventive + abortive  |  Atogepant + Ubrogepant  |  IV  |  No |  0%  |   52 weeks  |
 <html><!-- <html><!--

Trace:

Print/export
QR Code
QR Code mig (generated for current page)